The purpose of this study was to evaluate whether the 12-lead ECG could be substituted by ECG sets with a limited number of leads. Materials and methods: The performance of three ECG systems (ie ...

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia assessment. The ...

DocGo (DCGO) announced an expanded partnership with SHL Telemedicine (SHLT) to integrate the SmartHeart portable 12-lead ECG device across ...

HeartBeam announced today that it received FDA 510(k) clearance for its comprehensive arrhythmia assessment system.

As noted above, the precordial leads are unreliable, compromising by their inclusion calculations deriving from the set of 12 ECG leads. It appears, therefore, that using sums of data from the six ...

DocGo, a mobile medical services provider, has expanded its partnership with SHL Telemedicine to integrate its 12-lead ECG devices across its mobile healthcare network nationwide, according to Stock ...

HeartBeam (NASDAQ: BEAT), a medical technology company revolutionizing cardiac care, announced its participation in the JP Morgan 2025 Annual Healthcare Conference, set for Jan. 13-16, 2025, in San ...

In a time when pharmaceutical companies no longer have the economic luxury of decades-long development cycles, indication ...

Company to initiate Early Access Program to gain important patient and physician feedback on the use of the system in ...

The Tempus ECG-AF algorithm is intended for use to analyze recordings of 12-lead electrocardiogram (ECG) devices and to detect signs associated with a patient experiencing AF within the next 12 months ...

HeartBeam (NASDAQ: BEAT) , a medical technology company revolutionizing cardiac care, announced its participation in the JP Morgan 2025 Annual Healthcare Conference, set for Jan. 13-16, 2025, in San ...